What is GAMMAGARD LIQUID
Intravenous (IV)?
About GAMMAGARD
LIQUID IV
GAMMAGARD LIQUID IV is an infusion that is administered into a vein. Patients with Primary Immunodeficiency (PI) will typically receive IV infusions every 3 or 4 weeks. The IV infusions may be given in a hospital, an infusion center, or at home by a nurse.
Sustained protection against infection
In the IV administration clinical study of 61 patients with PI, GAMMAGARD LIQUID was shown to be effective at a dose of 300 to 600 mg/kg every 3 to 4 weeks for 12 months.
0ASBIs
There were no cases of validated acute serious bacterial infections (ASBIs)
0hospitalizations
No patients were hospitalized
due to infection
4other bacterial
infections
There were 4 occurrences of validated other bacterial infections reported*
*The validated other bacterial infections were urinary tract infection (1), gastroenteritis (sometimes called “stomach flu”) (1), and ear infection (2)
Demonstrated tolerability
In a total of 1,812 infusions in the clinical study, the most common side effect for GAMMAGARD LIQUID IV was headache (5.2%).
The most common side effects (seen in ≥5% of patients) were headache, fatigue, fever, nausea, chills/shaking chills, pain in the hands or feet, diarrhea, migraine, dizziness, vomiting, cough, hives, asthma, sore throat, rash, joint pain, muscle pain, swelling in the arms or legs, itching, and heart murmur. Learn more about GAMMAGARD LIQUID’s safety and side effects.
considered mild to moderate
95% of the 400 side effects reported in this study were
considered mild (217) to moderate (164). The remaining 5% (19)
were severe.
Please click here for more details about GAMMAGARD LIQUID's side effects and safety information.
GAMMAGARD LIQUID brochure
Download a PDF of our patient brochure, which provides additional information about PI and treatment with GAMMAGARD LIQUID IV.
Getting started
What would help you feel truly cared for? GAMMAGARD LIQUID offers options, so you and your doctor can create an infusion experience that's right for you.
Explore your optionsSafety and side effects
When you—or someone you love—starts a new treatment, discussing safety is one of the most important conversations you can have with your doctor.
Learn about safety